TipRanks
Scinai Immunotherapeutics (DE:2F50)
FRANKFURT:2F50
Germany Market
2F50
Scinai Immunotherapeutics
RESEARCH TOOLSreports

Scinai Immunotherapeutics (2F50) Income Statement

0 Followers

Scinai Immunotherapeutics Income Statement

Last quarter (Q2 2026), Scinai Immunotherapeutics's total revenue was $467.90K, an increase of 21.06% from the same quarter last year. In Q2, Scinai Immunotherapeutics's net income was $-2.04M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 1.31M$ 658.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.65M$ -580.00K$ 0.00$ 0.00$ -747.65K
Operating Expenses
$ 4.89M$ 8.06M$ 9.71M$ 11.06M$ 10.05M
Depreciation and Amortization
$ 1.42M$ 1.65M$ 514.00K$ 562.00K$ 747.65K
EBITDA
$ -6.53M$ -6.99M$ -2.19M$ -5.23M$ -10.05M
Operating Income
$ -7.54M$ -8.64M$ -9.71M$ -11.06M$ -10.79M
Other Income/Expenses
$ -765.00K$ 13.43M$ 3.21M$ 5.26M$ -1.58M
Pretax Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -12.38M
Net Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -12.38M
Per Share Metrics
Basic EPS
$ -36.00$ 60.00$ -64.00K$ -160.00K$ -3.51M
Diluted EPS
$ -36.00$ 60.00$ -64.00K$ -160.00K$ -3.51M
Weighted Average Shares Outstanding
 233.49K 80.64K 97.00 47.00 3.00
Weighted Average Shares Outstanding (Diluted)
 233.49K 80.64K 97.00 47.00 3.00
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History